Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Horina, JH; Fazekas, F; Niederkorn, K; Payer, F; Valetitsch, H; Winkler, HM; Horner, S; Freidl, W; Pogglitsch, H; Krejs, GJ.
Cerebral hemodynamic changes following treatment with erythropoietin.
Nephron. 1991; 58(4):407-412
Doi: 10.1159/000186471
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Horina Joerg
- Co-Autor*innen der Med Uni Graz
- Fazekas Franz
- Freidl Wolfgang
- Horner Susanna
- Krejs Günter Josef
- Niederkorn Kurt
- Payer Franz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Adverse hemorheologic effects induced by erythropoietin (EPO) treatment of renal anemia may pose a cerebrovascular risk. We therefore investigated the changes in cerebral perfusion, cerebral blood flow velocity (BFV) and neuropsychologic performance in 11 patients (mean age 37 years) receiving EPO. In response to EPO there was a significant (p less than 0.01) increase in hematocrit (35%), hemoglobin (43%) and whole-blood viscosity (50% at high and 90% at low shear rate). The initially increased blood flow velocity dropped significantly (p less than 0.05) and returned toward normal values in the middle cerebral arteries and the basilar artery (22 and 19% decrease, respectively). Global cerebral blood flow (CBF) decreased by 10% (not significant). The score of the Wechsler Adult Intelligence Scale digit symbol test improved significantly (p less than 0.01) after EPO treatment. None of the patients developed cerebrovascular symptoms or side effects. We conclude that the hematologic and rheologic changes following EPO treatment cause CBF and BFV to return toward normal and improve neuropsychologic performance in patients with end-stage renal disease.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Anemia - drug therapy Anemia - etiology Anemia - physiopathology
- Blood Flow Velocity - drug effects
- Cerebrovascular Circulation - drug effects
- Cerebrovascular Disorders - etiology
- Erythropoietin - adverse effects
- Female -
- Hemodynamics - drug effects
- Humans -
- Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy
- Male -
- Middle Aged -
- Renal Dialysis -
- Find related publications in this database (Keywords)
- Renal Anemia
- Erythropoietin
- Hemorheologic Effects
- Cerebral Hemodynamics
- Neuropsychological Performance